There is no single main cause of breast cancer. It develops from a combination of genetic, hormonal, and lifestyle factors that interact over time. If one factor stands above the rest, it’s prolonged exposure to estrogen and progesterone, the hormones that drive cell growth in breast tissue. These hormones are involved in the majority of breast cancer cases, and nearly every major risk factor, from obesity to early menstruation to alcohol use, traces back to how much estrogen your breast cells encounter over a lifetime.
About 30% of breast cancer risk can be attributed to inherited genetics. The rest comes from hormonal patterns, body composition, environmental exposures, and factors researchers still don’t fully understand. Here’s how each piece fits together.
Estrogen Exposure Is the Common Thread
Estrogen and progesterone fuel the growth of breast cells. That’s their normal job during puberty, menstrual cycles, and pregnancy. But when breast cells divide more frequently, there are more opportunities for DNA copying errors, and those errors can accumulate into cancer. Estrogen has been called the most important risk factor in breast cancer’s development, and the science supports that label. In lab studies, estrogen directly promotes breast cancer cell proliferation by pushing cells through their growth cycle faster.
This is why so many breast cancer risk factors are really estrogen-exposure factors in disguise. Starting your period earlier means more years of monthly estrogen surges. Going through menopause later extends those years further. Being overweight after menopause keeps estrogen levels elevated through a different mechanism entirely. About 80% of breast cancers are hormone receptor-positive, meaning the cancer cells have receptors that respond to estrogen, progesterone, or both.
How Reproductive Timing Shapes Risk
A massive analysis of nearly 119,000 women with breast cancer found that risk increased by 5% for every year younger a woman was at her first period. Separately, risk increased about 3% for every year older she was at menopause. Starting your period at 11 instead of 14, for example, adds roughly 15% more risk from that factor alone. These effects compound: a woman who starts menstruating early and reaches menopause late has a substantially longer window of hormonal exposure to breast tissue.
Interestingly, the added risk per year is greater at the beginning of reproductive life than at the end. One extra year of estrogen exposure during adolescence raises risk more than one extra year before menopause. Premenopausal women also had a 43% higher risk of breast cancer than postmenopausal women of the same age, reinforcing that active hormonal cycling matters.
Genetics and Family History
Inherited gene changes account for a meaningful but minority share of breast cancer cases. The most well-known are changes in the BRCA1 and BRCA2 genes. Women who carry a harmful variant in either gene have a lifetime breast cancer risk above 60%, compared to about 13% for women in the general population. That’s a roughly fivefold increase.
Beyond BRCA1 and BRCA2, researchers have identified changes in several other genes (including PALB2, ATM, and CHEK2) that raise risk to varying degrees. On top of those, more than 90 common genetic variants each add a small amount of risk individually. Taken together, all known genetic variants explain about 37% of the excess risk that runs in families. The rest of familial risk likely comes from gene variants not yet discovered, shared environments, or interactions between genes and lifestyle factors that are difficult to measure.
Body Weight and Estrogen After Menopause
After menopause, the ovaries stop producing estrogen. But fat tissue picks up some of that production through an enzyme that converts other hormones into estrogen. Women who are overweight or obese after menopause face roughly three times the breast cancer risk of normal-weight postmenopausal women. The reason is straightforward: more fat tissue means more of that converting enzyme, which means more estrogen circulating in and around breast cells.
What makes this particularly potent is proximity. Fat tissue within the breast itself produces estrogen right next to the cells most vulnerable to it. Obesity also triggers inflammatory signals that further ramp up local estrogen production in breast tissue. This creates a feedback loop where excess weight generates both more estrogen and more inflammation, each amplifying the other’s effect on breast cell growth.
Alcohol’s Dose-Dependent Effect
Alcohol is one of the clearest modifiable risk factors for breast cancer, and the relationship is linear: more alcohol means more risk, with no safe threshold identified. A pooled analysis of 53 studies covering over 58,000 breast cancer cases found that each standard drink consumed daily raised breast cancer risk by about 7%. Women who drank three to four drinks per day had a 32% higher risk than non-drinkers. Those who consumed more than four drinks daily had a 46% higher risk.
Alcohol raises estrogen levels, interferes with the body’s ability to process certain nutrients that protect DNA, and generates compounds that can directly damage cellular DNA. Unlike some risk factors you can’t control, this one is entirely modifiable.
Breast Density as an Independent Factor
Dense breast tissue, which contains more connective and glandular tissue relative to fat, is both a risk factor for breast cancer and a barrier to detecting it on mammograms. Women with extremely dense breasts have roughly 4.6 times the breast cancer risk of women with almost entirely fatty breasts, and about twice the risk of women with average density.
Dense tissue contains a higher proportion of the cell types where breast cancer originates. More cells means more cell division, and more cumulative exposure to hormones and growth signals over time. Breast density is partly genetic and partly influenced by hormonal factors, body weight, and age. It tends to decrease after menopause but varies widely from person to person.
Radiation Exposure, Especially in Youth
Ionizing radiation to the chest area, particularly before age 20, significantly increases long-term breast cancer risk. This is most relevant for women who received radiation therapy for childhood cancers like Hodgkin lymphoma. The relationship between radiation dose and breast cancer risk follows a linear pattern down to relatively low doses. Younger age at exposure carries the greatest risk because breast tissue is still developing and cells are dividing rapidly, making them more vulnerable to DNA damage.
HER2 and Non-Hormonal Pathways
Not all breast cancers are driven by estrogen. About 15 to 20% of cases involve overproduction of a protein called HER2, which sends constant “grow and divide” signals to breast cells. When the gene responsible for HER2 produces too many copies of itself, cells multiply uncontrollably. HER2-positive breast cancers tend to be more aggressive but respond to treatments specifically designed to block that protein’s signaling.
Triple-negative breast cancers, which lack estrogen receptors, progesterone receptors, and HER2 overexpression, account for about 10 to 15% of cases. These cancers arise through different molecular pathways and are more common in younger women and women with BRCA1 mutations.
Age Is the Strongest Non-Modifiable Factor
The median age at breast cancer diagnosis is 63. Nearly 70% of new cases occur in women aged 55 and older, with the highest concentration between ages 65 and 74. Only about 2% of cases are diagnosed in women under 35. Age matters because DNA damage accumulates over decades of cell division, hormonal exposure compounds year after year, and the body’s ability to repair genetic errors declines. Put simply, the longer breast cells have been dividing, the more chances something goes wrong.
This is also why risk factors interact with each other. A woman with dense breast tissue, early menarche, and a family history of breast cancer faces a compounded risk that’s greater than any single factor would predict on its own. Breast cancer is rarely caused by one thing. It’s the result of multiple exposures, vulnerabilities, and biological processes converging over time, with estrogen exposure running through most of them like a common thread.